Ovintiv Inc. (OVV)

Negative net income growth while BTE stands at 146.96%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.

Both reduce yoy usage, with BTE at -173.25%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.

Negative yoy usage while BTE is 0.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.

Well above BTE's 54.72%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.

Both yoy CFO lines are negative, with BTE at -20.08%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.

CapEx growth well above BTE's 22.78%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.

Both yoy lines negative, with BTE at -146.63%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.

Negative yoy purchasing while BTE stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.

We reduce yoy sales while BTE is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.

Growth well above BTE's 122.27%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.

Both yoy lines negative, with BTE at -4.54%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.

No Data available this quarter, please select a different quarter.